Iovance’s AMTAGVI (lifileucel) gets US FDA accelerated approval for advanced melanoma EP News Bureau Feb 19, 2024 AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after…
